Search results
FDA Approves First mRNA RSV Vaccine
MedPage Today· 4 days agoThe vaccine will be Moderna's second marketed product, in addition to its SARS-CoV-2 mRNA-1273 vaccine (Spikevax). The FDA's approval ...
The new technology inside COVID-19 vaccines— mRNA
KRGV Rio Grande Valley· 2 days agoWhen you think of vaccines, you may think about traditional vaccines with weak or inactive parts of a virus to trigger an immune response. Today...
FDA approves Moderna’s mRNA RSV vaccine for older adults | CNN
CNN.com· 4 days agoThe US Food and Drug Administration has approved another vaccine to help protect older people from...
US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label
Reuters· 4 days agoModerna's vaccine was approved for the prevention of RSV-associated lower respiratory tract disease...
Moderna Scores FDA Approval For Its Second Product - Respiratory Syncytial Virus Vaccine
Benzinga via AOL· 4 days agoThe approval was granted under a breakthrough therapy designation and marks the second approved mRNA...
Moderna's RSV Vaccine Approved by FDA
Medscape· 1 day agoFor the first time, an mRNA vaccine has been approved for an indication other than COVID-19. The vaccine& ...
FDA approves Moderna's RSV shot for older adults
Becker’s Hospital Review· 1 day agoThe FDA has given the green light to Moderna's mRNA-based respiratory syncytial virus vaccine, specifically for older adults, the drugmaker announced May ...
1 Beaten-Down S&P 500 Dividend Stock to Buy in June and Hold For a Decade or Longer
Motley Fool via Yahoo Finance· 7 hours agoPfizer's Abrysvo is one of three new respiratory syncytial virus (RSV) vaccines approved to prevent...
Moderna (MRNA) Secures FDA Nod for mRNA-Based RSV Vaccine
Zacks via Yahoo Finance· 1 day agoThe RSV vaccine is Moderna???s (MRNA) second FDA-approved product. Once the vaccine secures the...
Moderna’s vaccine for RSV gets FDA approval for people 60 and older - The Boston Globe
The Boston Globe· 4 days agoModerna said Friday that US drug regulators have approved its second product, a vaccine for...
